December 23, 2024

Mushrooming Mystery: How Fungal Infections Echo Alzheimer’s Disease in the Brain

Connecting the Fungus and Alzheimers Disease
” Our laboratory has years of experience studying fungis, so we started the study of the connection in between C. albicans and Alzheimers disease in animal designs,” stated matching author Dr. David Corry, Fulbright Endowed Chair in Pathology and teacher of pathology and immunology and medicine at Baylor. He likewise is a member of Baylors Dan L Duncan Comprehensive Cancer Center. “In 2019, we reported that C. albicans does get into the brain where it produces changes that are extremely similar to what is seen in Alzheimers illness. The current research study extends that work to understand the molecular systems.”
” Our very first question was, how does C. albicans go into the brain? We found that C. albicans produces enzymes called produced aspartic proteases (Saps) that breakdown the blood-brain barrier, offering the fungus access to the brain where it causes damage,” stated very first author Dr. Yifan Wu, postdoctoral researcher in pediatrics working in the Corry laboratory.
Fungal Clearance Mechanisms
Next, the scientists asked, how is the fungi successfully cleared from the brain? Corry and his associates had actually previously revealed that a C. albicans brain infection is totally dealt with in otherwise healthy mice after 10 days. In this study, they reported that this occurred thanks to two mechanisms activated by the fungus in brain cells called microglia.
” The exact same Saps that the fungus uses to break the blood-brain barrier also break down the amyloid precursor protein into AB-like peptides,” Wu stated. “These peptides trigger microglial brain cells through a cell surface area receptor called Toll-like receptor 4, which keeps the fungi load low in the brain, however does not clear the infection.”
C. albicans also produces a protein called candidalysin that likewise binds to microglia by means of a various receptor, CD11b. “Candidalysin-mediated activation of microglia is vital for clearance of Candida in the brain,” Wu said. “If we take away this pathway, fungis are no longer effectively cleared in the brain.”
New Insights on Alzheimers Disease Development
” This work potentially contributes a crucial brand-new piece of the puzzle regarding the development of Alzheimers illness,” Corry said. “The existing description for this condition is that it is mainly the outcome of the accumulation of harmful Ab-like peptides in the brain that leads to neurodegeneration. The dominant thinking is that these peptides are produced endogenously, our own brain proteases break down the amyloid precursor proteins producing the toxic Ab peptides.”
Here, the scientists reveal that the Ab-like peptides likewise can be generated from a different source– C. albicans. This common fungus, which has been found in the brains of individuals with Alzheimers disease and other persistent neurodegenerative conditions, has its own set of proteases that can produce the very same Ab-like peptides the brain can create endogenously.
” We propose that the brain Ab-peptide aggregates that characterize several Candida-associated neurodegenerative conditions consisting of Alzheimers illness, Parkinsons disease, and others, might be generated both intrinsically by the brain and by C. albicans,” Corry said. “These findings in animal models support conducting additional research studies to examine the function of C. albicans in the development of Alzheimers disease in individuals, which can possibly result in innovative therapeutic techniques.”
Referral: “Toll-like receptor 4 and CD11b expressed on microglia coordinate elimination of Candida albicans cerebral mycosis” by Yifan Wu, Shuqi Du, Lynn H. Bimler, Kelsey E. Mauk, Léa Lortal, Nessim Kichik, James S. Griffiths, Radim Osicka, Lizhen Song, Katherine Polsky, Lydia Kasper, Peter Sebo, Jill Weatherhead, J. Morgan Knight, Farrah Kheradmand, Hui Zheng, Jonathan P. Richardson, Bernhard Hube, Julian R. Naglik and David B. Corry, 10 October 2023, Cell Reports.DOI: 10.1016/ j.celrep.2023.113240.

Researchers from Baylor College of Medicine checked out the function of the fungi Candida albicans in the advancement of Alzheimers disease. Through animal designs, they discovered that the fungi breaches the blood-brain barrier utilizing enzymes and can produce amyloid beta (Ab)- like peptides, hazardous protein fragments thought to be central to Alzheimers.
A study from Baylor College of Medicine found that the fungi Candida albicans can produce poisonous peptides linked to Alzheimers disease, recommending the fungus may play a function in its advancement. This new insight warrants additional research for potential treatments.
Previous research has actually linked fungis in persistent neurodegenerative conditions such as Alzheimers disease, however there is limited understanding of how these common microbes could be associated with the development of these conditions.
Working with animal designs, researchers at Baylor College of Medicine and working together institutions discovered how the fungi Candida albicans gets in the brain, triggers two separate mechanisms in brain cells that promote its clearance, and, important for the understanding of Alzheimers disease development, produces amyloid beta (Ab)- like peptides, toxic protein pieces from the amyloid precursor protein that are thought about to be at the center of the development of Alzheimers disease. The study was released on October 10 in the journal Cell Reports.

” Our lab has years of experience studying fungi, so we embarked on the research study of the connection between C. albicans and Alzheimers illness in animal designs,” stated matching author Dr. David Corry, Fulbright Endowed Chair in Pathology and teacher of pathology and immunology and medicine at Baylor. “In 2019, we reported that C. albicans does get into the brain where it produces changes that are extremely similar to what is seen in Alzheimers disease. Next, the researchers asked, how is the fungi successfully cleared from the brain? In this research study, they reported that this occurred thanks to 2 mechanisms triggered by the fungus in brain cells called microglia.
“If we take away this path, fungis are no longer effectively cleared in the brain.”